Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 161

Similar articles for PubMed (Select 22008655)


Newer drugs and earlier treatment: impact on lifetime cost of care for HIV-infected adults.

Sloan CE, Champenois K, Choisy P, Losina E, Walensky RP, Schackman BR, Ajana F, Melliez H, Paltiel AD, Freedberg KA, Yazdanpanah Y; Cost-Effectiveness of Preventing AIDS Complications (CEPAC) investigators.

AIDS. 2012 Jan 2;26(1):45-56. doi: 10.1097/QAD.0b013e32834dce6e.


Are long-lasting insecticide-treated bednets and water filters cost-effective tools for delaying HIV disease progression in Kenya?

Verguet S, Kahn JG, Marseille E, Jiwani A, Kern E, Walson JL.

Glob Health Action. 2015 Jun 10;8:27695. doi: 10.3402/gha.v8.27695. eCollection 2015.


IANUA: a regional project for the determination of costs in HIV-infected patients.

Giannini B, Gazzarata R, Orcamo P, Merlano C, Cenderello G, Venturini A, Di Biagio A, Mazzarello G, Montefiori M, Ameri M, Setti M, Viscoli C, Cassola G, Giacomini M.

Stud Health Technol Inform. 2015;210:241-5.


Field Evaluation of a Point-of-Care CD4 Analyzer for Monitoring HIV Patients in the Interior of the Amazon Region, Brazil.

Pinto IC, Sabidó M, Pereira AB, Mello MB, de Melo Xavier Shimizu A, Protti BL, Benzaken AS.

PLoS One. 2015 Apr 23;10(4):e0121400. doi: 10.1371/journal.pone.0121400. eCollection 2015.


Projected Lifetime Healthcare Costs Associated with HIV Infection.

Nakagawa F, Miners A, Smith CJ, Simmons R, Lodwick RK, Cambiano V, Lundgren JD, Delpech V, Phillips AN.

PLoS One. 2015 Apr 22;10(4):e0125018. doi: 10.1371/journal.pone.0125018. eCollection 2015.


Assessment of the impact of cotrimoxazole prophylaxis on key outcomes among HIV-infected adults in low- and middle-income countries: a systematic review.

Saadani Hassani A, Marston BJ, Kaplan JE.

J Acquir Immune Defic Syndr. 2015 Apr 15;68 Suppl 3:S257-69. doi: 10.1097/QAI.0000000000000486. Review.


The impact of HIV care and support interventions on key outcomes in low- and middle-income countries: a literature review--introduction.

Kaplan JE, Hamm TE, Forhan S, Saadani Hassani A, Bang G, Weyant E, Tchuenche M, Langley C, Lapidos-Salaiz I, Bateganya MH.

J Acquir Immune Defic Syndr. 2015 Apr 15;68 Suppl 3:S253-6. doi: 10.1097/QAI.0000000000000495. No abstract available.


Point-of-care CD4 testing to inform selection of antiretroviral medications in south african antenatal clinics: a cost-effectiveness analysis.

Ciaranello AL, Myer L, Kelly K, Christensen S, Daskilewicz K, Doherty K, Bekker LG, Hou T, Wood R, Francke JA, Wools-Kaloustian K, Freedberg KA, Walensky RP.

PLoS One. 2015 Mar 10;10(3):e0117751. doi: 10.1371/journal.pone.0117751. eCollection 2015.


The lifetime medical cost savings from preventing HIV in the United States.

Schackman BR, Fleishman JA, Su AE, Berkowitz BK, Moore RD, Walensky RP, Becker JE, Voss C, Paltiel AD, Weinstein MC, Freedberg KA, Gebo KA, Losina E.

Med Care. 2015 Apr;53(4):293-301. doi: 10.1097/MLR.0000000000000308.


Life expectancy among HIV-positive patients in Rwanda: a retrospective observational cohort study.

Nsanzimana S, Remera E, Kanters S, Chan K, Forrest JI, Ford N, Condo J, Binagwaho A, Mills EJ.

Lancet Glob Health. 2015 Mar;3(3):e169-77. doi: 10.1016/S2214-109X(14)70364-X.


Cost-effectiveness of genotype testing for primary resistance in Brazil.

Luz PM, Morris BL, Grinsztejn B, Freedberg KA, Veloso VG, Walensky RP, Losina E, Nakamura YM, Girouard MP, Sax PE, Struchiner CJ, Paltiel AD.

J Acquir Immune Defic Syndr. 2015 Feb 1;68(2):152-61. doi: 10.1097/QAI.0000000000000426.


Determinants of HIV outpatient service utilization according to HIV parameters.

Di Carlo P, Immordino P, Mazzola G, Colletti P, Alongi I, Mineo M, Scognamillo M, Vitale F, Casuccio A.

J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19611. doi: 10.7448/IAS.17.4.19611. eCollection 2014.


Effect of management strategies and clinical status on costs of care for advanced HIV.

Barnett PG, Chow A, Joyce VR, Bayoumi AM, Griffin SC, Sun H, Holodniy M, Brown ST, Cameron W, Sculpher M, Youle M, Anis AH, Owens DK.

Am J Manag Care. 2014 May;20(5):e129-37.


Scaling-up the use of generic antiretrovirals in resource-limited countries: generic drugs for health.

Beck EJ, Passarelli C, Lui I, Guichard AC, Simao M, De Lay P, Loures L.

Antivir Ther. 2014;19 Suppl 3:117-23. doi: 10.3851/IMP2906. Epub 2014 Oct 13. Review.


Budget impact analysis of antiretroviral less drug regimen simplification in HIV-positive patients on the Italian National Health Service.

Restelli U, Andreoni M, Antinori A, Bonfanti M, Di Perri G, Galli M, Lazzarin A, Rizzardini G, Croce D.

Clinicoecon Outcomes Res. 2014 Sep 23;6:409-14. doi: 10.2147/CEOR.S68101. eCollection 2014.


The clinical and economic impact of point-of-care CD4 testing in mozambique and other resource-limited settings: a cost-effectiveness analysis.

Hyle EP, Jani IV, Lehe J, Su AE, Wood R, Quevedo J, Losina E, Bassett IV, Pei PP, Paltiel AD, Resch S, Freedberg KA, Peter T, Walensky RP.

PLoS Med. 2014 Sep 16;11(9):e1001725. doi: 10.1371/journal.pmed.1001725. eCollection 2014 Sep.


HIV economic burden of illness in the Veterans Health Administration population.

Wang L, Haider S, Nedrow K, Chambers R, Tawadrous M, Baser O, Simpson KN.

AIDS Care. 2015;27(1):123-31. doi: 10.1080/09540121.2014.947237. Epub 2014 Sep 16.


Disease prevention: saving lives or reducing health care costs?

Grootjans-van Kampen I, Engelfriet PM, van Baal PH.

PLoS One. 2014 Aug 12;9(8):e104469. doi: 10.1371/journal.pone.0104469. eCollection 2014.


Increased costs of HIV care associated with aging in an HIV-infected population.

Krentz HB, Gill MJ.

HIV Med. 2015 Jan;16(1):38-47. doi: 10.1111/hiv.12176. Epub 2014 Aug 8.


Cost-effectiveness of different strategies to monitor adults on antiretroviral treatment: a combined analysis of three mathematical models.

Keebler D, Revill P, Braithwaite S, Phillips A, Blaser N, Borquez A, Cambiano V, Ciaranello A, Estill J, Gray R, Hill A, Keiser O, Kessler J, Menzies NA, Nucifora KA, Vizcaya LS, Walker S, Welte A, Easterbrook P, Doherty M, Hirnschall G, Hallett TB.

Lancet Glob Health. 2014 Jan;2(1):e35-43. doi: 10.1016/S2214-109X(13)70048-2. Epub 2013 Dec 10.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk